menu search

Nektar shares halve on cancer trial failure

Cancer drug bempeg was an important one for biotech Nektar and its partner Bristol Myers Squibb....

March 14, 2022, 9:26 am

Genmab: a biotech company on the rise

Genmab enjoyed a strong 2021, recording revenues that have been able to maintain the majority of the growth seen in 2020....

March 12, 2022, 4:00 pm

2 top biotech stocks with huge potential

Below stocks have been added to my watchlist....

March 12, 2022, 11:31 am

Are biotech stocks a good investment for retirement?

If you have the right attitude and a good strategy in hand, they might be....

March 12, 2022, 11:23 am

Why crispr therapeutics stock soared this week

The biotech stock is making gains despite market pressures, but it's still down roughly 71% from its hi...

March 11, 2022, 7:49 pm

Cellectis to participate in two upcoming investor conferences in march

NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology com...

March 11, 2022, 4:30 pm

3 biotechs that will crush the bear

Our roundtable likes Doximity, Outset Medical, and Pieris Pharmaceuticals to outperform in 2022....

March 11, 2022, 4:00 pm

Top biotech penny stocks to buy now? 3 to watch in march

Check these three biotech penny stocks out for your watchlist The post Top ...

March 11, 2022, 2:31 pm

Champions oncology to announce third quarter financial results on tuesday, march 15, 2022

HACKENSACK, NJ / ACCESSWIRE / March 11, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled ...

March 11, 2022, 8:30 am

Investors hoping for news at cancer meeting that will boost share prices

Given that developing biotechnology companies are more susceptible to swings in stock price than established ones, investors might want to keep an eye...

March 10, 2022, 5:30 pm

Neximmune to present at the barclays 2022 global healthcare conference

GAITHERSBURG, Md., March 10, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel appro...

March 10, 2022, 4:26 pm

Arcellx announces participation at the barclays global healthcare conference

FOSTER CITY, Calif., March 10, 2022 /PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a clinical-stage cell therapy biotechnology company, announced today...

March 10, 2022, 4:26 pm

Moderna ceo's total compensation rose 41% in 2021, while the stock soared 143%

Moderna Inc. MRNA, -3.82% disclosed that Chief Executive Stéphane Bancel's 2021 salary got a 4.7% bump from the year before, while his total compensa...

March 10, 2022, 11:34 am

Cyclo therapeutics to present at the oppenheimer 32nd annual healthcare conference

GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechn...

March 10, 2022, 8:05 am

Windtree to present at oppenheimer's 32nd annual healthcare conference

WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused o...

March 10, 2022, 8:00 am

Could moderna's next step be worth billions?

The biotech company has set an ambitious goal for 2025....

March 10, 2022, 6:00 am

Wednesdays with wedbush: 3 smid-cap biotech stock picks

Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and treatments. That has put the ...

March 9, 2022, 12:03 pm

Adaptive biotechnologies to lay off ~12% of its workforce, names tycho peterson as cfo

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) will be organized around two distinct business areas - Minimal Residual Disease (MRD) and Immune ...

March 9, 2022, 10:37 am

Infinity pharmaceuticals to present at the 32nd annual oppenheimer healthcare conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a firs...

March 9, 2022, 8:35 am

Shattuck labs to present two posters at the 2022 american association for cancer research (aacr) annual meeting

AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology compa...

March 9, 2022, 8:21 am


Search within

Pages Search Results: